Sex Differences in Primary Care-Based Chronic Kidney Disease Management.
作者信息
Rodriguez Jorge A, Chen Sarah W, Gao Chenxi, Lipsitz Stuart R, Mendu Mallika L, Samal Lipika
机构信息
Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA. 2024 Jul 2;332(1):72-74. doi: 10.1001/jama.2024.8914.
Abstract
摘要
相似文献
1
Sex Differences in Primary Care-Based Chronic Kidney Disease Management.基于初级保健的慢性肾脏病管理中的性别差异。
JAMA. 2024 Jul 2;332(1):72-74. doi: 10.1001/jama.2024.8914.
2
Quality of chronic kidney disease management in primary care: a retrospective study.基层医疗中慢性肾脏病管理的质量：一项回顾性研究。
Scand J Prim Health Care. 2016;34(1):73-80. doi: 10.3109/02813432.2015.1132885. Epub 2016 Feb 6.
3
The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.胱抑素C检测在慢性肾脏病诊断和管理中的临床效用及成本影响：一项初级保健队列研究
PLoS Med. 2017 Oct 10;14(10):e1002400. doi: 10.1371/journal.pmed.1002400. eCollection 2017 Oct.
4
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.老年人低分子量血清蛋白滤过标志物的非肾小球滤过率决定因素：AGES-肾脏研究和MESA-肾脏研究
Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.
5
The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?慢性肾脏病流行病学协作组胱抑素 C（CKD-EPI-CysC）方程对有症状多发性骨髓瘤初诊患者的总生存具有独立的预后价值；是否到了从 MDRD 方程转变为 CKD-EPI-CysC 方程的时候？
Eur J Haematol. 2013 Oct;91(4):347-55. doi: 10.1111/ejh.12164. Epub 2013 Aug 17.
6
Making treatment guideline recommendations in chronic kidney disease and type 2 diabetes more accessible to primary care providers in the United States.使美国的初级保健提供者更容易获得慢性肾脏病和 2 型糖尿病治疗指南建议。
Postgrad Med. 2024 May;136(4):347-357. doi: 10.1080/00325481.2024.2350924. Epub 2024 May 11.
7
Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex.基于胱抑素C的估算肾小球滤过率的公式，不纳入种族和性别因素。
N Engl J Med. 2023 Jan 26;388(4):333-343. doi: 10.1056/NEJMoa2203769.
8
Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial.电子决策支持在初级保健中管理 CKD：一项实用随机试验。
Am J Kidney Dis. 2020 Nov;76(5):636-644. doi: 10.1053/j.ajkd.2020.05.013. Epub 2020 Jul 22.
9
Evaluation of Beta 2-Microglobulin, Cystatin C, and Lipocalin-2 as Renal Biomarkers for Patients with Fabry Disease.评估β2-微球蛋白、胱抑素 C 和脂联素-2 作为法布里病患者的肾脏生物标志物。
Nephron. 2019;143(4):217-227. doi: 10.1159/000500570. Epub 2019 Jun 19.
10
Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.早期慢性肾脏病的肾脏病共同管理与初级保健单独管理：一项回顾性横断面分析。
BMC Nephrol. 2015 Oct 12;16:162. doi: 10.1186/s12882-015-0154-x.
引用本文的文献
1
Electronic decision aids enhance management of primary care patients with steatotic liver disease: Proof of concept pilot study.电子决策辅助工具可改善原发性脂肪性肝病患者的基层医疗管理：概念验证性试点研究。
Hepatol Commun. 2025 Sep 5;9(9). doi: 10.1097/HC9.0000000000000794. eCollection 2025 Sep 1.
2
Twenty years population-based trends in prevalence, awareness, treatment, and control of hypertension in Geneva, Switzerland.瑞士日内瓦20年来基于人群的高血压患病率、知晓率、治疗率和控制率趋势
Prev Med Rep. 2025 Apr 1;53:103055. doi: 10.1016/j.pmedr.2025.103055. eCollection 2025 May.
3
Efficacy and safety of dapagliflozin in patients with CKD: real-world experience in 93 Italian renal clinics.达格列净在慢性肾脏病患者中的疗效与安全性：意大利93家肾脏诊所的真实世界经验
Clin Kidney J. 2024 Dec 3;18(1):sfae396. doi: 10.1093/ckj/sfae396. eCollection 2025 Jan.
4
CKD in reproductive-aged women: a call for early nephrology referral and multidisciplinary care.育龄期女性的慢性肾脏病：呼吁早期肾病转诊及多学科护理。
BMC Nephrol. 2024 Dec 3;25(1):444. doi: 10.1186/s12882-024-03864-9.
Zotero 插件